RHT's profits. But that is reality and RHT does protect its clients.
"
(“Reliq” or the “Company”), a rapidly growing global medtech company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed contracts with five new US clients, including three physician practices, a home health agency and a hospice provider. “We are pleased to be adding three primary care practices, a home health agency and a hospice care provider as new clients,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “As the Omicron variant raises new concerns about COVID transmission this winter, clinicians are even more motivated to keep their high-risk patients healthy and at home. Reliq’s iUGO Care platform helps protect chronic disease patients by allowing them to receive high quality healthcare in their own homes, avoiding the potential exposure to COVID and flu viruses in clinic and hospital settings. These five new contracts will add over 2,000 new Medicare patients to our platform in Q1 Calendar Year 2022 at an average revenue of over $50 USD per patient per month. Onboarding will begin in the new year.”
Reliq Health
Reliq Health Technologies is a rapidly growing global medtech company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.